NTAP
64
-2
SRE
50
20
SLB
56
8
NAVI
38
2
M
31
4
MOS
29
7
NFLX
61
-8
COP
50
8
F
46
4
CPB
44
4
SCHW
52
3
LMT
42
2
XRAY
16
-7
KR
40
-10
SRCL
54
-13
BA
45
3
PEG
46
5
EW
38
-2
TXT
75
2
YUM
52
9
NTAP
64
-2
SRE
50
20
SLB
56
8
NAVI
38
2
M
31
4
MOS
29
7
NFLX
61
-8
COP
50
8
F
46
4
CPB
44
4
SCHW
52
3
LMT
42
2
XRAY
16
-7
KR
40
-10
SRCL
54
-13
BA
45
3
PEG
46
5
EW
38
-2
TXT
75
2
YUM
52
9
Financhill
Back

Citigroup Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
40

C
Citigroup

Last Price:
61.58
Seasonality Move:
1.16%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
40
Citigroup (C) is a Sell

Is Citigroup a Buy, Sell or Hold?

  • The current Citigroup [C] share price is $61.34. The Score for C is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • C is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

C Stock Price Chart

What is Citigroup's stock price today?

  • The Citigroup share price today is $61.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and C is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

C Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 50.49 Buy
Chaikin Money Flow: 6563977 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.24 - 63.16) Sell
Bollinger Bands (100): (56.54 - 62.8) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

C Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.3 Buy
20-day SMA: 61.18 Buy
50-day SMA: 61.63 Sell
200-day SMA: 52.63 Buy
8-day EMA: 60.6 Buy
20-day EMA: 61.08 Buy
50-day EMA: 61.06 Buy
200-day EMA: 55.38 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Citigroup Earnings Growth & C Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.26 per share, an increase this year of $0.22 per share, and an increase next year of $1.32 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Citigroup Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):